Editorial
Published on 22 Mar 2023
Editorial: Pulsed electric field based technologies for oncology applications
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1183900
- 2,207 views
- 3 citations
Type at least 3 characters
1,724 articles
Articles
Case Report
Published on 22 Mar 2023
Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1084456
- 2,458 views
- 4 citations
Review
Published on 21 Mar 2023
Treatment strategies for clear cell renal cell carcinoma: Past, present and future
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1133832
- 12,955 views
- 19 citations
Mini Review
Published on 17 Mar 2023
In-vivo magnetic resonance spectroscopy of lactate as a non-invasive biomarker of dichloroacetate activity in cancer and non-cancer central nervous system disorders
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1077461
- 2,635 views
- 4 citations
Original Research
Published on 14 Mar 2023
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1140730
- 3,781 views
- 8 citations
Original Research
Published on 13 Mar 2023
High-throughput drug screening identifies fluoxetine as a potential therapeutic agent for neuroendocrine prostate cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1085569
- 2,807 views
- 1 citation
Original Research
Published on 10 Mar 2023
Loss of liver kinase B1 in human seminoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1081110
- 979 views
Original Research
Published on 10 Mar 2023
LIM1 contributes to the malignant potential of endometrial cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1082441
- 2,216 views
- 2 citations
Original Research
Published on 08 Mar 2023
PSGL-1 is a novel tumor microenvironment prognostic biomarker with cervical high-grade squamous lesions and more
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1052201
- 2,176 views
- 6 citations
Review
Published on 07 Mar 2023
Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1071030
- 3,220 views
- 6 citations
Original Research
Published on 07 Mar 2023
JNJ-64619178 radiosensitizes and suppresses fractionated ionizing radiation-induced neuroendocrine differentiation (NED) in prostate cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1126482
- 2,583 views
- 3 citations
Systematic Review
Published on 03 Mar 2023
Prognostic value of nectin-4 in human cancers: A meta-analysis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1081655
- 3,571 views
- 6 citations
Original Research
Published on 03 Mar 2023
Identification of the novel therapeutic targets and biomarkers associated of prostate cancer with cancer-associated fibroblasts (CAFs)
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1136835
- 3,431 views
- 8 citations
Original Research
Published on 28 Feb 2023
Metabolic classification of non-small cell lung cancer patient-derived xenografts by a digital pathology approach: A pilot study
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1070505
- 1,807 views
- 1 citation
Original Research
Published on 27 Feb 2023
Chimeric antigen receptor-T cells are effective against CEACAM5 expressing non-small cell lung cancer cells resistant to antibody-drug conjugates
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1124039
- 5,263 views
- 9 citations
Original Research
Published on 27 Feb 2023
Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospital
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1104659
- 1,750 views
- 3 citations